Very important pharmacogene summary ADRB2
- 1 January 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pharmacogenetics and Genomics
- Vol. 20 (1), 64-69
- https://doi.org/10.1097/fpc.0b013e328333dae6
Abstract
No abstract availableThis publication has 68 references indexed in Scilit:
- β1‐ and β2‐Adrenoceptor polymorphisms and cardiovascular diseasesBritish Journal of Pharmacology, 2009
- Diverse Evolutionary Histories for β-adrenoreceptor Genes in HumansAmerican Journal of Human Genetics, 2009
- Common ß-adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery diseaseHeart Rhythm, 2008
- Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterationsMetabolism, 2007
- Sequence, Haplotype, and Association Analysis ofADRβ2in a Multiethnic Asthma Case-Control StudyAmerican Journal of Respiratory and Critical Care Medicine, 2006
- β2-Adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmaticsHuman Genetics, 2006
- β2-Adrenergic Receptor Genotype and Survival Among Patients Receiving β-Blocker Therapy After an Acute Coronary SyndromeJAMA, 2005
- β2 Adrenoceptor Functional Gene Variants, Obesity, and Blood Pressure Level Interactions in the General PopulationHypertension, 2003
- The Arg16Gly polymorphism of human β2-adrenoreceptor is associated with type 2 diabetes in Taiwanese peopleClinical Endocrinology, 2002
- β 2 -Adrenergic Receptor Gene Variation and Hypertension in Subjects With Type 2 DiabetesHypertension, 2001